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Endocrine disrupting chemicals (EDCs) can interfere with normal hormonal balance and
may exert adverse consequences on humans. The male reproductive system may be susceptible to the effects of such environmental toxicants. This review discusses the recent
progress in scientific data mainly from epidemiology studies on the associations between
EDCs and male reproductive health and our understanding of possible mechanisms associated with the effects of EDCs on male reproductive health. Finally, the review provides
recommendations on future research to enhance our understanding of EDCs and male
reproductive health.The review highlights the need for (1) well-defined longitudinal epidemiology studies, with appropriately designed exposure assessment to determine potential
causal relationships; (2) chemical and biochemical approaches aimed at a better understanding of the mechanism of action of xenoestrogens with regard to low-dose effects,
and assessment of identify genetic susceptibility factors associated with the risk of adverse
effects following exposure to EDCs.
Keywords: endocrine disruptors, bisphenol A, phthalates, polychlorinated biphenyls, dichlorodiphenyltrichloroethane, dichlorodiphenyldichloroethylene

INTRODUCTION
Endocrine disrupting chemicals (EDCs) are estrogen-like and/or
anti-androgenic compounds that disrupt and interfere with the
production, release, transport, metabolism, binding, or elimination of natural hormones in the body responsible for the
maintenance of homeostasis and the regulation of developmental processes (1). EDCs include persistent pesticides and herbicides, methoxychlor, biocides, heat stabilizers, and chemical catalysts, plastic contaminants, pharmaceuticals, or dietary components. Those exogenous compounds can arise from industrial and
domestic effluents or agricultural and urban runoff. The general
population continues to be exposed to EDCs through ingestion of
contaminated food, inhalation of contaminated air and dust, and
skin contact, while some areas are subjected to greater risk due to
geographical and cultural reasons (2). Due to temporal downward
trends in semen quality and testosterone levels and increased rates
of testicular cancers among adult male populations (3, 4), scientific researchers, and the general public have become increasingly
concerned regarding the potential risk of EDCs to men’s reproductive health. Cellular models and animal toxicological studies
have demonstrated that EDCs can exert adverse effects on the male
reproductive system. In humans, there are a growing number of
epidemiological studies about EDCs and detrimental reproductive
function. However, a potential decline in human male reproductive health and a link to exposure to endocrine active chemicals in
the environment has been controversial for almost two decades.
This article focuses on the review of the human data regarding
the relationship between exposures to known or suspected EDCs.
It specifically focuses on bisphenol A (BPA), phthalates, polychlorinated biphenyls (PCBs), and dichlorodiphenyltrichloroethane
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(DDT)/dichlorodiphenyldichloroethylene (DDE) and men’s
semen quality, sperm DNA damage, reproductive hormone levels,
and reproductive diseases. This review provides: (1) an introduction to several common EDCs and their sources, (2) an overview
of the state of the human evidence for adverse impacts of EDCs
on male reproductive health, and (3) a description of possible
mechanisms of action for EDCs involved with detrimental male
reproductive functions based on in vitro and in vivo studies, and
(4) recommendations for future research needed to enhance our
understanding of the effect of EDCs on male reproductive health.

ENDOCRINE DISRUPTORS
Polychlorinated biphenyls are a class of synthetic chlorinated compounds, which have been recognized as EDCs. PCBs were used
in industrial and consumer products such as transformers and
hydraulic fluids, and as an additive in paints, oils, and building
materials. The use and production of PCBs have been banned
since the 1970s, however, there has been no decrease or a slight
decrease in the environment since the middle of 1990s (5). There
is still considerable health risk from human exposure to PCBs from
consumption of contained foods (6).
Dichlorodiphenyltrichloroethane and its main metabolite
(p,p 0 -DDE) is a widespread, persistent environmental contaminant (7). Technical grade DDT is a mixture of p,p 0 -DDT (85%),
o,p 0 -DDT (15%), and o,o 0 -DDT (trace amounts). Both p,p 0 DDT and o,p 0 -DDT promote estrogenic activity (8). Reproductive abnormalities attributed to DDT/DDE exposure have been
reported in a variety of wildlife animals (9, 10) and in laboratory
rats (11). Epidemiological studies have recently addressed the link
between exposure to DDT and male reproductive health (12–15).
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Bisphenol A has been extensively used in production of polycarbonate plastic, epoxy resin, food packaging, and lacquers for
food cans. Human beings are primarily exposed to BAP via dietary
ingestion of leachings from the inner lining of cans and microware
containers during heating of food materials and via beverages in
polycarbonate bottles due to repeated usage or contact with any
acid/alkaline (16). BPA is prevalent in our environment and measurable levels have been detected in the majority of individuals.
Estrogenic activity of BPA was confirmed and is the basis for the
recognition of the compound as a known endocrine disruptor.
Phthalates are ubiquitous industrial chemicals that are reported
to adversely affect human reproductive outcomes. They are
divided into two distinct groups based on molecular weight and
with very different applications, toxicological properties, and classification: high molecular weight compounds (di-2-ethylhexyl
phthalate with alkyl chain lengths from 8 to 13 carbons) and low
molecular weight compounds [diethyl phthalate, dibutyl phthalate
(DBP)]. Phthalates also include three di-(2-ethylhexyl) phthalate (DEHP) metabolites, mono-(2-ethylhexyl) phthalate (MEHP)
and two oxidative metabolites, mono-(2-ethyl-5-hydroxyhexyl)
phthalate (MEHHP), and mono-(2-ethyl-5-oxohexyl) phthalate
(MEOHP). High molecular weight phthalates are primarily used
as plasticizers in the manufacture of flexible vinyl plastic which,
in turn, is used in consumer products, flooring and wall coverings, and medical devices (17). Low molecular weight phthalates
are used in personal-care products as solvents and plasticizers
for cellulose acetate. Exposure through ingestion, inhalation, and
dermal contact are considered important routes of exposure for
the general population. Upon exposure, phthalates are rapidly
metabolized and excreted in urine and feces (17). Measurement
of urinary concentrations of phthalate metabolites has been used
as the most common biomonitoring approach for investigating
human exposure to phthalates.

ASSOCIATIONS BETWEEN EDCs AND SEMEN QUALITY
The testicle seems to be an important target organ for PCBs, which
can disrupt sperm production and development (18). PCBs had
a consistent, significant inverse association with sperm motility,
while its relationship with sperm concentration was less inconsistent (Table 1). An association with lower sperm concentrations
likely occurred only at higher PCB concentrations. Men who had
serum PCB levels of 240 ng/g lipid and partners diagnosed with
an inability to conceive a pregnancy were associated with lower
sperm concentrations (19). Bonde et al. selected 2,20 ,4,40 ,5,50 hexachlorobiphenyl (CB-153) as a marker of PCB congeners and
found that the non-coplanar PCB congeners only affected sperm
motility, whereas the coplanar dioxin-like PCB congener CB-77
also reduced sperm counts (20).
The available epidemiological evidence suggests that exposure
to high DDT concentrations has links to semen quality (Table 1).
The studies in malaria-endemic areas, where DDT was sprayed
consistently, show an association between higher serum DDT concentration and decreased semen quality (13, 33). However, such
associations were not found in studies conducted in populations
where DDT/DDE concentrations were lower. DDT/DDE negatively impacted sperm motility, morphology, count, and semen
volume in a South African population of 311 young males living
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in a malaria area in the Limpopo Province (33). Other studies
also observed that DDT exposure adversely affected sperm quality,
mainly through decreased motility (12–15). DDT can negatively
affect sperm quality, especially when high concentration levels are
considered.
Various animal models of BPA exposure have shown multiple effects on the male reproductive system, including inhibition
of the development of seminiferous tubules and spermatogenesis,
and impaired semen quality (43, 44). Increasing evidence from
epidemiological studies has revealed the relationship between
exposure to BPA and sperm quality, however, that relationship
seemingly occurs at high concentrations of BPA exposure. BPA
concentration at 1.55 ng/mL in male partners of sub-fertile couples
may influence sperm count (31) based on a reverse relationship
between BPA concentration and sperm count. A cross-sectional
study performed on a population of 20 healthy men showed that
serum BPA level positively correlated with quick forward progression of sperm and was inversely correlated with the percentage of
normal sperm (45). In a recent study of 360 fertile men, Mendiola et al. demonstrated that no correlation existed between
urinary BPA levels and semen quality, while BPA was inversely
correlated with free androgen index concentrations (28). Meeker
et al. recorded a similar finding showing a non-significant trend
of increasing BPA levels related to lower sperm concentration,
motility, morphology, and higher levels of DNA damage (27). A
follow-up study on 190 male partners attending an infertility clinic
showed that urinary BPA concentration were not associated with
semen quality parameters, but they were positively associated with
sperm DNA damage (38).
Toxicological studies have consistently shown that phthalate
metabolites are reproductive and developmental toxicants. There
is evidence that pubertal and adult exposure to DEHP results
in testicular toxicity and impaired spermatogenesis (46, 47). In
the past decade, an increasing number of epidemiological studies have investigated associations between phthalate metabolites
and semen quality, but results have not been consistent. One
of the first studies investigated 168 men from sub-fertile couples and concluded that specific phthalate metabolites correlated
with lower sperm concentration and motility. There were dose–
response relations between mono-butyl phthalate (MBP) and
semen quality (motility and concentration), but limited evidence
existed for such relations between other phthalate metabolites and
poor sperm morphology and concentration (23). In a follow-up
study with emphasis on sperm motion parameters, the authors
reported that monobenzyl phthalate (MBzP), MBP, and MEHP
have associations with velocity, while no relationship was found
for mono-methyl phthalate (MMP) and any sperm motion parameter (48). A recent re-analysis of their data with 463 men again
found significant dose–response associations between MBP concentration and low sperm concentration and low motility (24). A
recent study of 344 men who had normal semen concentration
of 20–300 × 106 /mL showed that urinary phthalate metabolites
[5OH-MEHP, MEHP, mono-isobutyl phthalate (MiBP)] levels
were significantly associated with a decrease in sperm motility
(26). Weak associations between exposure to phthalate metabolites and lower sperm concentration, motility and morphology in
adults have been reported by several studies (24, 25, 48, 49); at
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Table 1 | Epidemiological studies on semen quality and endocrine disruptors including phthalates, BPA, PCB, and DDT/DDE.
Compound

Study design

Sample size and subjects

Age

Concentration

Semen quality

First author (year)

DEP

Cross-sectional

300 Healthy males

29

0.64–3.11 µg/mL

↓ Concentration

Pant et al. (21)

DBP

Cross-sectional

300 Healthy males

29

0.18–1.65 µg/mL

↓ Concentration,

Pant et al. (21)

PHTHALATE

motility
DBP

Cross-sectional

300 Healthy males

28–29

13.47 µg/mL

↓ Motility, viability

Pant et al. (22)

DEHP

Cross-sectional

300 Healthy males

28–29

5.73 µg/mL

↓ Motility, viability

Pant et al. (22)

MEP

Cross-sectional

168 Male partners of

36

175.5 ng/mL

No relationship

Duty et al. (23)

36

180 ng/mL

No association

Hauser et al. (24)

35

121.9 ng/mL

↓ Concentration

Wirth et al. (25)

sub-fertile couples
MEP

Cross-sectional

463 Male partners of
sub-fertile couples

MEP

Cross-sectional

45 Male partners of sub-fertile
couples

MEP

Cross-sectional

269 Male from infertility clinic

32

153.6 µg/mL

No relation

Jurewicz et al. (26)

MBP

Cross-sectional

168 Male partners of

36

16.1 ng/mL

↓ Concentration,

Duty et al. (23)

sub-fertile couples
MBP

Cross-sectional

463 Male partners of

motility, morphology
36

17.3 ng/mL

sub-fertile couples
MBP

Cross-sectional

45 Male partners of sub-fertile

↓ Concentration,

Hauser et al. (24)

motility
35

26.9 ng/mL

No association

Wirth et al. (25)

32

108.5 µg/mL

No association

Jurewicz et al. (26)

36

8.0 ng/mL

No association

Hauser et al. (24)

36

7.6 ng/mL

No association

Duty et al. (23)

35

11.5 ng/mL

No association

Wirth et al. (25)

32

18.4 µg/mL

↓ Motility

Jurewicz et al. (26)

36

7.5 ng/mL

↓ Morphology

Duty et al. (23)

36

3.6 ng/mL

No association

Hauser et al. (24)

35

1.1 ng/mL

No association

Wirth et al. (25)

35

2.5 ng/mL

↓ Morphology

Wirth et al. (25)

36

1.3 ng/mL

↓ Concentration,

Meeker et al. (27)

couples
MBP

Cross-sectional

269 Males from infertility
clinic

MEHP

Cross-sectional

463 Male partners of
sub-fertile couples

MEHP

Cross-sectional

168 Male partners of
sub-fertile couples

MEHP

Cross-sectional

45 Male partners of sub-fertile
couples

MEHP

Cross-sectional

269 Males from infertility
clinic

MMP

Cross-sectional

168 Male partners of
sub-fertile couples

MMP

Cross-sectional

463 Male partners of
sub-fertile couple

MMP

Cross-sectional

45 Male partners of sub-fertile
couples

MCPP

Cross-sectional

45 Male partners of sub-fertile
couples

BPA

Cross-sectional

190 Male from infertility clinic

motility, morphology
BPA

Cross-sectional

375 Male partners of

32 (18–53)

1.5 µg/L

No association

Mendiola et al. (28, 29)

pregnant women
(Continued)
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Table 1 | Continued
Compound

Study design

Sample size and subjects

Age

Concentration

Semen quality

First author (year)

BPA

Cross-sectional

218 Males

N/A

1.6–5.9 µg/L

↓ Sperm

Li et al. (30)

concentration,
motility, viability, count
BPA

Prospective cohort

142 Male partners of

34

1.55 ng/mL

sub-fertile couples
PCB

Pilot study

29 Male partners of

↓ Concentration,

Knez et al. (31)

vitality, count
33

242 ng/g lipids

↓ Motility

Hauser et al. (19)

35

43 ng/g lipids

↓ Motility

Hauser et al. (32)

35

223 ng/g lipids

↓ Motility

Hauser et al. (32)

infertile/sub-fertile couples
PCB

Cross-sectional

303 Male partners of
sub-fertile couple

PCB

Cross-sectional

303 Male partners of
sub-fertile couples

p,p 0 DDT

Cross-sectional

311 Healthy males

23 (18–40)

90.23 µg/g lipid

↓ Motility

Aneck-Hahn et al. (33)

p,p 0 -DDE

Cross-sectional

24 Healthy male

21 (16–28)

77.9 µg/g lipid

↓ Volume, count

Ayotte et al. (34)

p,p 0 -DDE

Cross-sectional

116 Healthy males

27

45.0 µg/g lipid

↓ Motility, morphology

de Jager et al. (13)

p,p 0 -DDE

Case–control

73 Healthy males

25

1.05 µg/g lipid

No relationship

Charlier and Foidart (35)

p,p 0 -DDE

Cross-sectional

195 Healthy males

24–65

240 ng/g lipid

No relationship

Rignell-Hydbom et al. (12)

No relationship

Hauser et al. (15)

↓ Motility

Hauser et al. (19)

(80–887)
p,p 0 -DDE

Cross-sectional

212 Sub-fertile males

28–45

220 ng/g lipid
(72.5–7776)

p,p 0 -DDE

Pilot study

29 Male partners of

33

354 ng/g lipid

infertile/sub-fertile couples
DBP, Di-n-butyl phthalate; DEHP, Di(2-ethylhexyl) phthalate; MEP, monoethyl phthalate; MbzP, monobenzyl phthalate; MBP, mono-n-butyl phthalate; MEHP, mono2-ethylhexyl phthalate; MMP, mono-methyl phthalate; MEOHP, mono-(2-ethyl-5-oxohexyl) phthalate; MiBP, mono-isobutyl phthalate; MEHHP, mono-(2-ethyl-5hydroxyhexyl) phthalate; MCPP, mono-(3-carboxypropyl) phthalate, N/A, no data available.

the same time, some have not proven this connection to phthalate
metabolites (MBP or MBzP) (50). The aforementioned studies
have many important differences, including the age range of the
study populations, healthy status of the study populations, differences in the analytical methods used to measure phthalates,
adjustment for covariance, and exposure concentrations.

DNA INTEGRITY
Sperm DNA integrity represents an essential requirement for
the accurate transmission of genetic information. The origin of
human sperm DNA damage involves certain mechanisms, including (1) alterations in chromatin modeling during the process of
spermiogenesis, (2) apoptosis, and (3) oxidative stress (51). Sperm
DNA damage has been characterized using the Comet assay (39),
the sperm chromatin structure assay (SCSA) (52), and terminal deoxynucleotidyl transferase-driven dUTP nick end labeling
(TUNEL) assay (53). Methods assessing sperm DNA integrity have
implications and applications for being a better predictor of both
in vivo and in vitro fertility than the WHO sperm parameters (54).
There is limited and contradictory epidemiological evidence
on whether PCBs can affect human sperm DNA (39, 52, 55).
PCBs positively associated with percentage of DNA fragmentation
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analyzed by the TUNEL assay and the neutral Comet assay (20).
Hauser et al. observed no statistically significant consistent associations between the Comet assay parameters and any of the individual PCB congeners or sum of PCBs (39). Reasons for this inconsistency might be different methodologies used to detect sperm DNA
damage, varying exposure ranges to and mixtures of persistent
organic compounds, and different inclusion criteria for the studies.
Spanò et al. studied whether p,p 0 -DDE was associated with
altered sperm chromatin integrity among European men. They
found no significant associations between p,p 0 -DDE serum concentrations and sperm chromatin integrity analyzed by the SCSA
(41). A following study conducted by Stronati et al. also observed
no correlation between p,p 0 -DDE and sperm DNA fragmentation of 652 adult Inuits. A study of a population of Mexican
men exposed to a mean concentration of 45,000 ng/g lipid from
DDT sprayed in the environment show that impaired sperm chromatin condensation was observed in 46.6% of participants (13).
Another study that was characterized by a mean p,p 0 -DDE level
of 90,230 ng/g for DDT reported 54.7% of the studied young
men had impaired sperm chromatin condensation. The percentage of damaged sperm chromatin structure measured by the flow
cytometric method had a weak, but positive relationship with
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Table 2 | Epidemiological studies on DNA integrity and endocrine disruptors including phthalates, BPA, PCB, and DDT/DDE.
Compound

Study design

Sample size

Age

Concentration

DAN integrity

First author (year)

Cross-sectional

68 Male partners of sub-fertile

36

186.8 ng/mL

↑ Tail distributed

Duty et al. (36)

PHTHALATE
MEP

couples

moment

MEP

Cross-sectional

379 Males from infertility clinic

36

171 ng/mL

↑ DNA damage

Hauser et al. (37)

MEP

Cross-sectional

269 Males from infertility clinic

32

153.6 µg/mL

No association

Jurewicz et al. (26)

MBP

Cross-sectional

168 Male partners of sub-fertile

36

18.2 ng/mL

No association

Duty et al. (36)

couples
MBP

Cross-sectional

379 Infertility clinic

36

17.9 ng/mL

↑ DNA damage

Hauser et al. (37)

MBP

Cross-sectional

269 Males from infertility clinic

32

108.5 µg/mL

↑ DNA damage

Jurewicz et al. (26)

MEHP

Cross-sectional

168 Male partners of sub-fertile

36

7.1 ng/mL

No association

Duty et al. (36)

couples
MEHP

Cross-sectional

379 Infertility clinic

36

7.6 ng/mL

↑ DNA damage

Hauser et al. (37)

MEHP

Cross-sectional

269 Males from infertility clinic

32

18.4 µg/mL

No association

Jurewicz et al. (26)

MMP

Cross-sectional

168 Males partners of sub-fertile

36

6.1 ng/mL

No association

Duty et al. (36)

couples
MMP

Cross-sectional

379 Infertility clinic

36

3.6 ng/mL

No relation

Hauser et al. (37)

BPA

Cross-sectional

190 Males from infertility clinic

36

1.3 ng/mL

↑ DNA damage

Meeker et al. (27)

BPA

Cross-sectional

132 Sub-fertile

37

Below limit of detection

↑ DNA damage

Meeker et al. (38)

(LOD)
PCB

Cross-sectional

212 Sub-fertile

28–45

226 ng/g lipid

No association

Hauser et al. (39)

PCB

Cross-sectional

707 Males from general population

34

180 ng/g lipid

↑ DNA

Spanò et al. (40, 41)

fragmentation
DDT/DDE

Cross-sectional

707 Healthy males

34

560 ng/g lipid

No relationship

Spanò et al. (40, 41)

p,p 0 -DDT

Cross-sectional

195 Healthy males

47

240 ng/g lipid (80–887)

No relationship

Rignell-Hydbom et al. (12)

p,p 0 -DDE

Cross-sectional

212 Sub-fertile males

28–45

220 ng/g lipid

No relationship

Hauser et al. (15)

(72.5–7776)
p,p 0 -DDE

Cross-sectional

680 Partners of pregnant women

34

750 ng/g lipid

↑ DNA damage

Giwercman et al. (42)

p,p 0 -DDE

Cross-sectional

707 Males from general population

34

790 ng/g lipid

No association

Spanò et al. (40, 41)

DDT concentrations. However, the percentage of DNA damage
and sperm chromatin structure defects were not correlated (56).
The finding was in agreement with other studies (40, 52). Some
epidemiological studies did not find any significant association
between DDT/DDE exposure and human sperm DNA (39, 52,
53). However, all of the preceding studies were characterized by a
relatively low level of exposure to DDT, as detected by the plasma
analysis of DDE, and where the main route of exposure to DDT
was through diet. Those studies suggested that additional factors (e.g., genetic background, lifestyle habits, characterization of
actual DDT mixture, and their xenohormonal activities) need to
be investigated in the future for a better understanding of the effect
of DDT exposure on sperm DNA integrity.
A few studies with cellular models indicated that BPA has
the potential to induce point mutation, double stranded DNA

www.frontiersin.org

breaks, and aneuploidy (57, 58; Table 2). Human studies of
BPA exposure and sperm DNA damage have been very limited. Meeker et al. assessed the relationship between urinary
BPA concentrations and sperm DNA damage in men recruited
through a United States infertility clinic. BPA has been associated with increased single-strand breaks of sperm DNA damage
among men. Since the studied population was recruited through
an infertility clinic, there is a limitation on the ability to generalize the results to the general population (27, 59). Another
follow-up study investigating relationships between urinary concentrations of parabens and BPA and male reproductive health
reported that both parabens and BPA were both positively associated with sperm DNA damage. The study did not reach conclusions regarding causal relationships due to the cross-sectional
design (38).
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Limited animal and epidemiologic data exist on the potential
general population effects of phthalate exposure on sperm DNA
integrity. In a US study, an association between increased sperm
DNA damage and MEP was found, but there were no associations
with the other phthalate monoesters (36; Table 2). A follow-up
study with a larger sample of men and measurement of two oxidative metabolites of DEHP reported consistent evidence of the
previous findings that MEP, a metabolite of diethyl phthalate, was
associated with increased DNA damage and MEHP, a metabolite
of DEHP, was associated with DNA damage after adjustment for
the oxidative DEHP metabolites (37). When analyzing six urinary phthalate metabolites from 344 men with normal semen
concentrations (20–300 mln/mL) or slight oligozoospermia (15–
20 × 106 /mL), Jurewicz et al. reported that urinary MBP levels
were significantly associated with an increase in sperm DNA damage (26). The same research group extended the preliminary study
by including a large sample of men and measurements of more
phthalate metabolites MEHP and MEOHP, two oxidative metabolites of DEHP. Sperm DNA damage was associated with MEHP
after adjusting for DEHP oxidative metabolites (26). By contrast,
a Swedish study did not find associations between any of the
phthalate monoesters and sperm DNA damage measured with the

SCSA (50). A recent study of 232 general population men from a
Reproductive Center in Chongqing, China, showed no association
between phthalate metabolites and sperm DNA damage using the
alkaline single-cell gel electrophoresis assay (60).

REPRODUCTIVE SYSTEM TRACK
Two congenital anomalies are included in the definition of the testicular dysgenesis syndrome (TDS): cryptorchidism and hypospadias. Cryptorchidism is the failure of one or both testicles to
descend into the scrotum, which likely occurs by 6 months of
age (61), thus study designs rely only on diagnosis in the delivery room are sub-optimal. Hypospadias, the condition in which
the opening of the urethra is on the ventral side of the penis
rather than that at the tip of the glans penis, can be diagnosed
reliably at birth. Hypospadias may arise during the first trimester
of in utero life and is classified as mild (first degree) to severe
(third degree), depending on where the urethra opens on the
penis. Eight studies have examined the relationship between cryptorchidism and/or hypospadias and DDT and/or metabolites of
DDT. Table 3 summarizes results from limited published studies
that have examined the association between PCBs and DDT and
either cryptorchidism or hypospadias. Two case–control studies

Table 3 | Case–control studies on relationships between cryptorchidism and hypospadias and endocrine disruptors including PCB and DDT/DDE.
Compound

Country

Outcome

Biospecimen

Cases

Controls

PCB

Germany

Cryptorchidism

Maternal sera

18

PCB

Faroe Islands

Cryptorchidism

Umbilical cord

PCB

France

Cryptorchidism

PCB

US

PCB

Italy

Results

First author (year)

30

Null

Hosie et al. (66)

19

176

Null

Mol et al. (63)

Cord blood

67

84

Null

Brucker-Davis et al. (64)

Cryptorchidism

Colostrum

56

69

Cryptorchidism

Maternal sera

230

593

Null

McGlynn et al. (65)

Hypospadias

Maternal sera

201

593

Hypospadias

Maternal sera

37

21

Null

Giordano et al. (67)

PCB

US

Hypospadias

Maternal sera

20

28

Null

Carmichael et al. (68)

p,p 0 -DDT o,p 0 -DDE

Germany

Cryptorchidism

Maternal sera

18

30

p > 0.05/p > 0.05

Hosie et al. (62)

p,p 0 -DDT o,p 0 -DDE

Denmark and Finland

Cryptorchidism

Breast milk

62

68

p = 0.47/p = 0.97

Damgaard et al. (69)

p,p 0 -DDT o,p 0 -DDE

Spain

Cryptorchidism

Placenta

48

114

p > 0.05/p > 0.05

Fernandez et al. (70)

Hypospadias
p,p 0 -DDE

Germany

Cryptorchidism

Maternal sera

18

30

p > 0.05

Hosie et al. (62)

p,p 0 -DDE

US

Cryptorchidism

Maternal sera

219

552

p > 0.05

Longnecker et al. (71)

Hypospadias

Maternal sera

199

552

p > 0.05

p,p 0 -DDE

US

Cryptorchidism
Hypospadias

Maternal sera
Maternal sera

75
66

283
283

p > 0.05
p > 0.05

Bhatia et al. (8)

p,p 0 -DDE

Denmark and Finland

Cryptorchidism

Breast milk

62

68

p = 0.26

Damgaard et al. (69)

p,p 0 -DDE

France

Cryptorchidism

Cord blood

67

84

p = 0.43

Brucker-Davis et al. (64)

Cryptorchidism

Colostrum

56

69

p = 0.11

p,p 0 -DDE

Italy

Hypospadias

Maternal sera

37

21

p > 0.05

Giordano et al. (67)

p,p 0 -DDE

US

Hypospadias

Maternal sera

20

28

p = 0.80

Carmichael et al. (68)
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of PCBs and cryptorchidism reported no relationship to risk
(62, 63), whereas a third offered measured support (64). One
ecologic study of PCBs and hypospadias reported an inverse
association (42). Because the sample sizes of prior studies may
have been too small to detect statistically significant differences,
a follow-up study was conducted among a large, well-described
population in which the serum samples were collected at a time
when PCB levels in the United States were higher. This study
analyzed PCBs in the third-trimester serum samples from the
mothers of 230 sons with cryptorchidism, 201 sons with hypospadias, and 593 sons with neither condition between 1959 and
1965, and did not strongly support the hypothesis that PCBs are
associated with cryptorchidism or hypospadias. Because population serum PCB levels at the time of sample collection were
considerably higher than levels at present, it is unlikely that
current PCB exposure is related to the development of either
anomaly (65).
In a rat model, DBP could prompt changes in testes and
male reproductive accessory glands, hypospadias, cryptorchidism,
retention of nipples, and reduced anogenital distance (48, 72).
Studies on laboratory animals have shown that exposure to
500–750 mg of DBP/kilogram during the critical period of male
reproductive development results in remarkable phenotypic alterations in normal development (73). At birth, males presented
with reduced anogenital distance. In adulthood, the phenotypes
included cryptorchidism, epididymal agenesis, testicular atrophy
with germ cell loss, hypospadias, and absent or smaller seminal
vesicles and prostate (74). In humans, evidence demonstrating a
negative action of phthalates on the reproductive tract is also accumulating. A relationship between anogenital distance and maternal urinary concentrations of phthalate metabolites was noted in
85 boys studied by Swan et al. (3). That study investigated the
effect of prenatal environmental exposure to phthalates on genital
development in newborns.

CANCERS
Studies investigating an association of DDT with endometrial cancer (75) and prostate and testicular cancer (76) have been inconclusive or do not support an association. Recently, increased exposure
to p,p 0 -DDE has been reported to associate with risk of both seminomatous and non-seminomatous testicular germ cell tumors
(TGCTs) (77). This case–control study investigated pre-diagnostic
serum samples from 754 case subjects and 928 control subjects
enrolled in the US Servicemen’s Testicular Tumor Environmental
and Endocrine Determinants (STEED) for DDT exposure. Subjects in the highest serum p,p 0 -DDE quartile (>0.390 µg/g lipid)
compared to those in the first serum p,p 0 -DDE quartile (0.157 µg/g
lipid) supported increased risk of TGCT in relation to exposure to
DDE and PCBs (78). On the other hand, DDE was not associated
with TGCT in a case–control study of 876 adult men in Washington State, U.S. (79). Finally, several small studies have suggested an
association between PCB exposure and prostate cancer (80, 81),
whereas no association was reported between PCBs and prostate
cancer in a recent Canadian study of 79 cases and 329 age frequency
matched controls (82).
As far as genotoxic and mutagenic effects of BPA are concerned, most studies are carried out in in vitro systems, which
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do not mimic the in vivo environment. BPA has been evaluated
in standard screens for mutagenicity including the Ames test,
mouse lymphoma, sister chromatid exchange, and mammalian
gene mutation assay. Most of the results indicated that BPA is not
mutagenic (83). However, some reports have indicated that BPA
has the potential to induce point mutation, double stranded DNA
breaks, and aneuploidy (57, 58). The National Toxicology Program (NTP) has evaluated the carcinogenic activity of BPA and
concluded that it was not a robust carcinogen in the context of
adult exposure (84). However, careful analysis of the same data
documented several shortcoming of the NTP study with respect
to effects observed on hematology of mice and testicular tumors,
age of animal as well as use of strain of rats and mice and their susceptibility to carcinogenic agents (85). Recent studies have shown
that prenatal exposure to BPA causes hyperplasia of prostate in
male rats resulting in greater risk of prostate cancer (86). Currently, there are few in vivo genotoxicity studies carried out in
bone marrow cells of mice upon BPA exposure at different time
intervals (1–5 days), which document that BPA failed to induce
chromosomal aberrations and micronuclei formation (87, 88).
Based on a few in vivo studies, it is impossible to draw a definite conclusion about genotoxic activity of BPA as it is estrogenic
in nature.
Most evidence depicting cancer risk associated with exposure
to EDC is limited to cellular and animal models. Although some
evidence shows associated TGCTs, there is no conclusive evidence
to indicate an increased risk of testicular cancer in men exposed
to EDCs.

MECHANISM(S) OF ACTION ON EDCs AFFECTING THE MALE
REPRODUCTIVE SYSTEM
Endocrine disrupting chemicals have long been known for their
estrogenic properties and the ability to compete with endogenous steroid hormones binding to receptors. EDCs were found
to disturb human male steroidogenesis, which alters reproductive hormones, a critical factor in spermatogenesis. Recent studies
provide new insights about other mechanisms, such as oxidative
stress, genetic susceptibility, and epigenetic effects, related to EDCs’
involvement with detrimental reproductive health outcomes.
STEROIDOGENESIS

Endocrine disrupting chemicals can act as anti-androgens, antiestrogens, and steroidogenic enzyme inhibitors that interfere with
steroid action/production as the mechanism to alter male reproductive health. Also, EDCs can interact with thyroid hormones and
their receptors or with the brain and the hypothalamo-pituitary
axis (89). Certain EDCs could inhibit the enzymes involved in
steroidogenesis, which leads to the reduction of hormones. Urinary phthalate metabolites and BPA levels were negatively associated with testosterone levels (29, 90), follicle-stimulating hormone
(FSH) (91), and luteinizing hormone (LH) (50). Phthalate esters
were observed to exert a direct effect on Leydig cell or Sertoli
cell structure with correlation of the in vitro and in vivo systems (92). DEHP was also observed to altered Sertoli and Leydig cell function during development and inhibit testosterone
production (93). DEHPs can exert their anti-androgenic action
by directly inhibiting testosterone synthesis in Leydig cells (94),
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which has been proposed to be a result of cytochrome CYP 17
dysfunction (95). Some phthalates have also been shown to disrupt the patterns of gene expression that regulate cholesterol and
lipid homeostasis or insulin signaling, which could also result
in lower testosterone synthesis (96). In addition, certain phthalate monoesters may interfere with the ability of Sertoli cells
to respond to their normal endogenous ligand of FSH (97).
The action site of the phthalate monoester was at the coupling of the FSH receptor-ligand complex to the transducing
G-protein within the Sertoli cell membrane (97). Among phthalate
metabolites, MEHP did not affect steroidogenesis in the H295R
steroidogenesis assay nor alter testosterone production in MA-10
cells (98, 99).
Bisphenol A was also observed to have an inverse relationship with reproductive hormones. A recent study showed that
the reduction of testosterone could be due to BPA-induced
inhibitory effect on the activity of ATP-binding cassette transporters of the cellular membrane of testicular tissues (100).
BPA has affinity to bind to estrogen receptors [estrogen receptor alpha (ERα) and estrogen receptor beta (ERβ)]. Knockout models for estrogen receptors have shown that they are
the pivotal players required for spermatogenesis, suggesting that
estrogen plays an important role in testicular development and
spermatogenesis (101).
Dichlorodiphenyltrichloroethane could cause a decrease in
transport of testicular androgen as a result of enhanced degradation (102). DDT and its metabolites (o,p 0 -DDT, and p,p 0 -DDE)
can inhibit endogenous ligand binding to the estrogen and androgen receptors. PCBs can disrupt estrogen receptor function by
mimicking the natural ligand and acting as an agonist (103).
OXIDATIVE STRESS

Recent evidence suggests oxidative stress may be one of the
mechanisms associated with the effect of phthalates acting as an
anti-androgenic compound on male reproductive health. Phthalates, mainly DEHP, DBP, or DEP, have been reported to alter the
activities of marker testicular enzymes of laboratory animals associated with the specific events of spermatogenesis, inducing ROS
production, lipid peroxidation, and apoptosis of spermatocytes.
One possible mechanism is that ROS generation might correlate
with DEHP-induced Ca2+ entry, potentially through the Ca2+ mediated activation of the nicotinamide adenine dinucleotide
phosphate (NADPH) complex (104). Recently, limited epidemiological studies have also reported that phthalate metabolites are
associated with oxidative stress. Fong et al. assessed the association between urinary phthalate metabolites in polyvinyl chloride
workers. After adjustment for age, smoking status, and coffee consumption, sperm apoptosis and ROS generation were positively
associated with urinary MEHHP, MEOHP, and MEHP (105). Specific signaling pathways mediate increased oxidative stress are
needed to confirm oxidative stress as a mechanism for the effect
on phthalate.
Bisphenol A could induce oxidative stress in fish spermatozoa
in vitro, which results in accumulation of LO and CP, together with
the modification of antioxidant system activity. These oxidative
responses were associated with spermatozoa quality depression,
as measured by a decrease in the values of spermatozoa motility
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and velocity (106). Adverse effects of the monomer in male rats
may be due to induction of oxidative stress in sperm (107). With
limited evidence to date, it is pre-mature to recognize oxidative
stress as the mechanism associated with the effect of BPA on male
reproductive capacity.
EPIGENETIC MECHANISM

Possible negative actions on progeny via epigenetic toxic mechanisms have recently been suggested. Epigenetic changes include
multiple mechanisms such as DNA methylation, histone modifications, and non-coding RNAs, which regulate gene expression
without affecting the gene sequence (108). Epigenetic modifications via DNA methylation are permanent changes, which are
transmitted to next generations (109). As indicated earlier, BPA
has reduced affinity to bind to estrogen receptors that could lead
to gene transcription and regulate DNA methylation in various
disease states. Doshi et al. demonstrated that neonatal exposure of
rats to BPA led to aberrant DNA methylation in testis, indicating
methylation mediated epigenetic changes as one of the possible
mechanisms of BPA-induced adverse effects on spermatogenesis
and fertility (110). Wu et al. observed that DEHP-induced changes
in DNA methylation, especially within CpG islands, and suggested
that changes in DNA methylation may be one possible mechanism
of DEHP-mediated testicular toxicity (111). Although emerging
observations further expand the possibility of epigenetic as a toxic
mechanism of EDCs but are yet to be verified in human studies.

FUTURE RESEARCH NEEDS
Current evidence has shown variability in study findings regarding
the relationship between endocrine disruptors and male reproductive health. Some possibilities explain the variability. First
of all, many of the potential exposure–response relationships
described here have not been adequately explored. Second, there
are differences among the studies, including differences in sample size, study design, study populations, life stage, data analysis
approaches, and/or strategies for attaining data on exposure, endpoint, and important covariates. Third, limitations are inherent
in epidemiological studies. For example, humans are not exposed
exclusively to the chemical being investigated, but instead to a
mixture of chemicals, some of them acting through common pathways. In addition, no single compound can act as a surrogate
or marker for the others because the contaminant profile varies
among individuals. Finally, different chemicals may have different
toxicokinetics.
Current evidence has provided a better understanding of the
impact of exposure to endocrine disruptors on male reproductive
health along with possible mechanisms. However, future studies
are needed to address inconclusive outcomes: (1) a well-defined
epidemiology study with cohorts of men in various populations
is required to evaluate the potential effect of external factors on
male reproductive health. Such a study should not be limited to
the analysis of sperm concentration, as this may not be the best
biomarker of testis function and human fertility; (2) human exposure assessment data does not uniformly support toxicity of the
substances at environmental concentrations. There is a need to
develop methods to better study mixtures of endocrine disruptors, such as exposure to multiple phthalates at different levels

June 2014 | Volume 2 | Article 55 | 8

Jeng

and how they may act additively or synergistically, or even antagonistically. Statistical methods should incorporate the biological
activity of the different phthalate metabolites, both the monoesters
and oxidative metabolites; (3) there is a clear need for chemical and biochemical approaches aimed at a better understanding
of the mechanism of action of xenoestrogens with regard to the
low-dose effects revealed during developmental exposure. These
approaches encompass several areas of study, such as signal transduction via membrane and nuclear ER, and analytical chemistry to
measure these chemicals and their metabolites in tissues. Humans
are exposed to a variety of endocrine disruptors acting through
many different pathways at different times during their development. This poses two problems for consideration: interactions
among chemicals acting through a common pathway and a single chemical affecting different pathways. A limited number of
studies have shown that certain EDCs could induce epigenetic
change. More studies are needed to confirm the results and any
association with altered reproductive dysfunction and the etiology of congenital anomalies by identifying tissue-specific genes
with changes in DNA methylation; and (4) identify susceptibility
factors that may increase risk of adverse effects following exposure
to EDCs. Genetic factors may modify the exposure–dose relationship by altering the metabolism or excretion of EDCs. Additionally,
genetic factors may modify dose–response relationships by altering the biological response to a given internal dose. More research
in this area of susceptibility is critical to our understanding of
human health risks.
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